Postoperative endocrine management of pituitary tumors

Neurosurgery Clinics of North America

Volumn 14, Issue 1, 2003, Pages 123-138

  Singer, Peter A ^a   Sevilla, Linda J ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; CARBAMAZEPINE; CHLORPROPAMIDE; CLOFIBRATE; DESMOPRESSIN; HALOPERIDOL; HYDROCORTISONE; NONSTEROID ANTIINFLAMMATORY AGENT; PROLACTIN; SOMATOMEDIN C; TETRACOSACTIDE; THIORIDAZINE; THYROTROPIN; VASOPRESSIN;

CLINICAL FEATURE; DIABETES INSIPIDUS; DIABETES MELLITUS; DIFFERENTIAL DIAGNOSIS; FLUID BALANCE; HUMAN; HYPONATREMIA; HYPOPHYSECTOMY; HYPOPHYSIS TUMOR; HYPOPITUITARISM; HYPOTHYROIDISM; INAPPROPRIATE VASOPRESSIN SECRETION; PATHOPHYSIOLOGY; PATIENT MONITORING; PLASMA OSMOLALITY; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROLACTINOMA; REVIEW; VASOPRESSIN RELEASE;

DIABETES INSIPIDUS; HUMANS; INAPPROPRIATE ADH SYNDROME; PITUITARY NEOPLASMS; POSTOPERATIVE CARE;

EID: 0037262593     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1042-3680(02)00032-3     Document Type: Review

References (120)

1. Clayton RN. Sporadic pituitary tumors: from epidemiology to use of databases. Best Practice and Research Clinical Endocrinology and Metabolism 1999;13:451-60.
2. Drange M, Fram N, Herman-Bonert V, et al. Pituitary Tumor Registry: novel clinical resource. J Clin Endocrinol Metab 2000;85:168-74.
3. Kurutsu J, Ushio Y. Epidemiological study of primary intracranial tumors: a regional survey in Kumamoto Prefecture in the southern part of Japan. J Neurosurg 1996;84:946-50.
4. Nilsson B, Gustavasson-Kadaka E, Bengtsson BA, et al. Pituitary adenomas in Sweden between 1958 and 1991: incidence, survival, and mortality. J Clin Endocrinol Metab 2000;85:1420-5.
5. Teramoto A, Hirakawa K, Sanno N, et al. Incidental pituitary lesions in 1,000 unselected autopsy specimens. Radiology 1994;193:161-4.
6. Black PM, Zervas NT, Candia G. Management of large pituitary adenomas by transsphenoidal surgery. J Surg Neurol 1988;29:4434-39.
7. Turner HE, Adams CB, Wass JA. Transsphenoidal surgery for microprolactinoma: an acceptable alternative to dopamine agonists? Eur J Endocrinol 1999;140:43-7.
8. Olson BR, Gunowski J, Rubino D, et al. Hyponatremia after transsphenoidal pituitary surgery. J Neurosurg 1997;87:499-507.
9. Sane T, Rantakari K, Poranen A, et al. Hyponatremia after transsphenoidal surgery for pituitary tumors. J Clin Endocrinol Metab 1994;79:1395-8.
10. Blumberg DL, Sklar CA, Wisoff J, et al. Abnormalities of water metabolism in children and adolescents following craniotomy for a brain tumor. Childs Nerv Syst 1994;10:505-8.
11. Zimmerman EA, Naliver G, Hou-Yu A, et al. Vasopressinergic and oxytocinergic pathways in central nervous system. Fed Proc 1984;43:91-6.
12. Bardsley PA, Johnson BF, Stewart AG, et al. Natriuresis secondary to carotid chemoreceptor stimulation with almitrine bismesylate in the rat: the effect on kidney function and the response to renal denervation and deficiency of ADH. Biomed Biochem Acta 1991;50:175-82.
13. Stevens AL, Breton S, Gustafson CE, et al. Aquaforin 2 is a vasopressin-independent, constitutive apical membrane protein in rat vas deferens. Am J Physiol Cell Physiol 2000;278:791-802.
14. Robertson GL, Mahr EA, Athar S, et al. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973;52:2340-52.
15. Caillens H, Pruszcyznski W, Meyrier A, et al. Relationship between change in volemia at constant osmolality and plasma antidiuretic hormone. Miner Electrolyte Metab 1980;4:161-71.
16. Dunn FL, Brennan JT, Nelson AE, et al. The role of blood osmolality and volume in regulating vasopressin secretion in the rat. J Clin Invest 1973;52:3212-9.
17. Robertson GL, Berl T. Water metabolism. In: Brenner BM, Rector Jr FC, editors. The kidney. Philadelphia: WB Saunders; 1986. p. 385-432.
18. Robertson GL. Vasopressin in osmotic regulation in man. Annu Rev Med 1974;25:315-22.
19. Robertson GL, Shelton RI, Athar S. The osmoregulation of vasopressin. Kidney Int 1976;10:25-37.
20. Sved AF. Central neural pathways in baroreceptor control of vasopressin secretion. In: Vasopressin. New York: Raven; 1985. p. 443-53.
21. Geelen G, Keil LC, Kravik SE, et al. Inhibition of plasma vasopressin after drinking in dehydrated humans. Am J Physiol 1984;247:968-71.
22. Wood RJ, Rolls ET, Rolls BJ. Physiological mechanisms for thirst in the nonhuman primate. Am J Physiol 1982;247:423-8.
23. McDonald KM, Kuruvila KC, Aisenbrey GA, et al. Effect of alpha and beta adrenergic stimulation on renal water excretion and medullary cyclic AMP in intact and diabetes insipidus rats. Kidney Int 1997;12:96-103.
24. Willoughby JO, Jervois PM, Menadue MF, et al. Noradrenaline, by activation of alpha-1-adrenoreceptors in the region of the supraoptic nucleus, causes secretion of ADH in the unanesthetized rat. Neuroendocrinology 1987;45:219-26.
25. Dillingham MA, Anderson RJ. Inhibition of ADH action by atrial natriuretic factor. Science 1986;231:1572-3.
26. Usberti M, Federico S, Cianciaruso B, et al. Effects of angiotensin II on plasma ADH, PGE2 synthesis, and water excretion in normal man. Am J Physiol 1985;248:254-9.
27. Masera N, Grant DB, Stanhope R, et al. Diabetes insipidus with impaired osmotic regulation in septo-optic dysplasia and agenesis of the corpus callosum. Arch Dis Child 1994;70:51-3.
28. Moses AM, Notman DD. Diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion (SIADH). Adv Intern Med 1973;27:73-100.
29. Randall RV, Clark EC, Dodge HW, et al. Polyuria after operating for tumors in the hypophysis and hypothalamus. J Clin Endocrinol Metab 1960;20:1614-20.
30. Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, et al. Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10 year experience in a single institution. Childs Nerv Syst 1998;14:276-9.
31. Seckl JR, Dunger DB. Postoperative diabetes insipidus. Correct interpretation of water balance and electrolyte data essential. BMJ 1989;298:2-3.
32. Seckl JR, Dunger DB, Bevan JS, et al. Vasopressin antagonist in early postoperative diabetes insipidus. Lancet 1990;335:1353-6.
33. Seckl JR, Dunger DB, Lightman SL. Neurophysiological peptide function during early postoperative diabetes insipidus. Brain 1987;110:737-46.
34. Singer I, Oster JR, Fishman LM. The management of diabetes insipidus in adults. Arch Intern Med 1997;157:1293-301.
35. Salata RA, Verbalis JG, Robinson AG. Cold water stimulation of oropharyngeal receptors in man inhibits release of vasopressin. J Clin Endocrinol Metab 1987;65:561-7.
36. Fahlbush R, Honegger J, Buchfelder M. Surgical management of acromegaly. Endocrinol Metab Clin North Am 1992;21:669-92.
37. McIver B, Connacher A, Whittle I, et al. Adipsic hypothalamic diabetes insipidus after clipping of anterior communicating artery aneurysm. BMJ 1991;303:1465-7.
38. Mudd RH, Dodge HW, Clark EC, et al. Experimental diabetes insipidus; a study of normal interphase. Proc Staff Meet Mayo Clin 1957;32:94-108.
39. Robertson GL, Harris A. Clinical use of vasopressin analogues. Hosp Pract 1989;24:114-39.
40. Williams TDM, Dunger DB, Lyon CC, et al. Antidiuretic effect and pharmacokinetics of oral 1-desamino S-D-arginine ADH, I: studies in adults and children. J Clin Endocrinol Metab 1986;63:129-32.
41. Fanestil DA. Hyposmolar syndromes. In: Andreoli TE, Grantham JJ, Rector FC, editors. Disturbances in body fluid osmolality. Bethseda: American Physiological Society; 1977. p. 267-84.
42. Anderson RJ, Chung H-M, Kluge R, et al. Hyponatremia: a prospective analysis of its epidemiology and the pathogenic role of vasopressin. Ann Intern Med 1985;102:164-8.
43. Chung H-M, Kluge R, Schrier RW, et al. Post-operative hyponatremia: a prospective study. Arch Intern Med 1986;146:333-6.
44. Gross PA, Pehrisch H, Rascher W, et al. Pathogenesis of clinical hyponatremia: observations of vasopressin and fluid intake in 100 hyponatremic medical patients. Eur J Clin Invest 1987;17:123-9.
45. Gross PA, Pehrisch H, Rascher W, et al. Vasopressin in hyponatremia: what stimuli. J Cardiovasc Pharmacol 1986;8(Suppl):S92-5.
46. Rose BD, Post TW. Hyposmolar-Hyponatremia. In: Clinical physiology of acid-base and electrolytes disorders. 5th edition. New York: McGraw-Hill; 2001. p. 729-33.
47. Ishikawa S, Saito T, Fukagawa A, et al. Close association of urinary excretion of AQP-2 with appropriate and inappropriate ADH-dependent antidiuresis in hyponatremia in elderly subjects. J Clin Endocrinol Metab 2001;86:1665-71.
48. Kovacs L, Robertson GL. Syndrome of inappropriate antidiuresis. Endocrinol Metab Clin North Am 1992;21:859-75.
49. Sorensen JB, Anderson MK, Hansen HN. SIADH in malignant disease. J Intern Med 1995;238:97-110.
50. Hund E, Bohrer H, Martin E, et al. Disturbances of water and electrolyte balance. In: Hacke W, editor. Neurocritical care. Berlin: Springer Verlag; 1994. p. 917-27.
51. Rose BD, Post TW. Hyposmolar-Hyponatremia. In: Clinical physiology of acid-base and electrolytes disorders. 5th edition. New York: McGraw-Hill; 2001. p. 707-11.
52. Sheikh-Hamad D, Ayus CJ. Antidiuretic hormone and renal clearance of uric acid. Am J Kidney Dis 1998;32:692-3.
53. Harrigan M. Cerebral salt wasting syndrome. A review. Neurosurgery 1996;38:152-60.
54. Arieff AI, Lach F, Massry SG. Neurological manifestations and morbidity of hyponatremia: correlation of brain water and electrolytes. Medicine (Baltimore) 1976;55:121-9.
55. Hirshberg B, Ben-Yehuda A. The syndrome of inappropriate antidiuretic hormone in the elderly. Am J Med 1997;103:270-3.
56. Donati-Genet PC, Dubius JM, Girardin E, et al. Acute symptomatic hyponatremia and cerebral salt wasting after head injury an important clinical entity. J Pediatr Surg 2001;36:1094-7.
57. Linas SL, Berl T, Robertson GL, et al. Role of vasopressin in the impaired water excretion of glucocorticoids deficiency. Kidney Int 1980;18:58-67.
58. Raff H. Glucocorticoid inhibition of neurohypophysial vasopressin secretion. Am J Physiol 1987;252:635-44.
59. Chinitz A, Turner FL. The association of primary hypothyroidism and inappropriate secretion of the antidiuretic hormone. Arch Intern Med 1965;116:871-4.
60. DiScala VA, Kinney MJ. Effects of myxedema on the renal diluting and concentrating mechanism. Am J Med 1971;50:325-35.
61. Schmitz PH, de Meijer PH, Meinders AE. Hyponatremia due to hypothyroidism: a pure renal mechanism. Neth J Med 2001;58:143-9.
62. Liu BA, Mittmann N, Knowles SR, et al. Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports. CMAJ 1996;155:519-27.
63. Anderson RJ. Hospital-associated hyponatremia. Kidney Int 1986;29:1237-47.
64. Hillier TA, Abbott RD, Barrett EJ. Hyponatremia: evaluating the correction factor for hyperglycemia. Am J Med 1999;106:399-403.
65. Andrews BT, Fitzgerald PA, Tyrell JB, et al Cerebralsalt wasting after pituitary exploration and biopsy: case report. Neurosurgery 1986;18:469-71.
66. Atkin SL, Coady AM, White MC, et al. Hyponatremia secondary to cerebral salt wasting syndrome following routine pituitary surgery. Eur J Endocrinol 1996;135:245-7.
67. Wijdicks E, Vermeulen M, Hijdra A, et al. Hyponatremia and cerebral infarction in patients with ruptured intracranial aneurysm: is fluid restriction harmful? Ann Neurol 1985;17:137-40.
68. Covey CM, Arieff AI. Disorders of sodium and water metabolism, and their effects on the central nervous system. In: Brenner BM, Stein JH, editors. Sodium and water homeostasis: contemporary issues in nephrology, vol. I. New York: Churchill Livingston; 1978;212-41.
69. Rose BD. New approach to disturbances in the plasma sodium concentration. Am J Med 1986;81:1033-40.
70. Albanese A, Hindmarsh P, Stanhope R. Management of hyponatremia in patients with acute cerebral insults. Arch Dis Child 2001;85:246-51.
71. Kleinschmidt-DeMasters BK, Norenberg MD. Rapid correction of hyponatremia causes demyelination: relation to central pontine myelinolysis. Science 1981;211:1068-70.
72. Messert B, Ornson WW, Hawkins MJ. Central pontine myelinolysis. Neurology 1979;29:147-60.
73. Ayus JC, Olivero JJ, Fromer JP. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution. Am J Med 1982;72:43-8.
74. Decaux G, Genette F. Urea for long term treatment of syndrome of inappropriate secretion of antidiuretic hormone. BMJ 1981;283:1081-3.
75. Decaux G, Waterlot Y, Genette F, et al. Treatment of the syndrome of inappropriate hormone with furosemide. N Engl J Med 1981;304:329-30.
76. Iranmanesh A, Lizarralde G, Veldhuis JD. Coordinate activation of the corticotropic axis by insulin-induced hypoglycemia: simultaneous estimates of beta endorphin, adrenocorticotropin and cortisol secretion and disappearance in normal men. Acta Endocrinol (Copenh) 1993;128:521-8.
77. Fragen RJ, Shanks CA, Molteni A, et al. Effects of etomidate on hormonal responses to surgical stress. Anesthesiology 1984;61:652-6.
78. Aron DC, Findling JW, Fitzgerald PA, et al. Cushing's syndrome: problems in management. Endocr Rev 1982;3:229-44.
79. Bigos ST, Somma M, Rasio E, et al. Cushing's disease: management by transsphenoidal pituitary microsurgery. J Clin Endocrinol Metab 1980;50:348-54.
80. Chandler WF, Schteingart DE, Lloyd RV, et al. Surgical treatment of Cushing's disease. J Neurosurg 1987;66:204-12.
81. Mampalam TJ, Tyrell JB, Wilson CB. Transsphenoidal microsurgery for Cushing's disease. A report of 216 cases. Ann Intern Med 1988;109:487-93.
82. Swearingen B, Biller BM, Barker FG II, et al. Long-term mortality after transsphenoidal surgery for Cushing's disease. Ann Intern Med 1999;130:821-4.
83. Wilson CB, Mindermann T, Tyrell JB. Extrasellar, intracavernous sinus adrenocorticotropin-releasing adenoma causing Cushing's disease. J Clin Endocrinol Metab 1995;80:1774-7.
84. Bochicchio D, Losa M, Buchfelder M. The European Cushing's Disease Survey Study Group. Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 1995;80:3114-20.
85. Orth DN. Medical progress: Cushing's syndrome. N Engl J Med 1995;332:791-803.
86. Styne DM, Grumbach MM, Kaplan SL, et al. Treatment of Cushing's disease in childhood and adolescence by transsphenoidal microadenomectomy. N Engl J Med 1984;310:889-93.
87. Biermasz NR, Van Dulken H, Roelfsema F. Ten year follow-up results of transsphenoidal microsurgery in acromegaly. J Clin Endocrinol Metab 2000;85:4596-602.
88. Freda PU, Wardlaw SL, Post KD. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly. J Neurosurg 1998;89:353-8.
89. Abosch A, Tyrell JB, Lamborn KR, et al. Transsphenoidal microsurgery for growth hormonesecreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998;83:3411-8.
90. Melmed S, Jackson I, Kleinberg D, et al. Current treatment guidelines for acromegaly. J Clin Endocrinol Metab 1998;83:2646-52.
91. Hirschberg R, Adler S. Insulin like growth factor system and the kidney physiology, pathophysiology and therapeutic implications. Am J Kidney Dis 1998;31:901-19.
92. Colao A, Marzullo P, Vallone G, et al. Reversibility of joint thickening in acromegalic patients: an ultrasonography study. J Clin Endocrinol Metab 1998;83:2121-5.
93. Jenkins D, O'Brien I, Johnson A, et al. The Birmingham pituitary database: Auditing the outcome of the treatment of acromegaly. Clin Endocrinol 1995;43:517-22.
94. Ross DA, Wilson CB. Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas in a series of 214 patients. J Neurosurg 1988;68:854-67.
95. Jho HD, Carrau RL. Endoscopic endonasal transsphenoidal surgery. Experience with 50 patients. J Neurosurg 1997;87:44-51.
96. Beck-Peccoz P, Persani L, Asteria C, et al. Thyrotropin secreting pituitary tumors in hyper and hypo thyroidism. Acta Med Austriaca 1996;23:41-6.
97. McDermott MT, Ridgeway EC. Central hyperthyroidism. Endocrinol Metab Clin North Am 1998;27:187-203.
98. Brucker-Davis F, Oldfield E, Skarulis M, et al. Thyrotropin secretin pituitary tumors: diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the NIH. J Clin Endocrinol Metab 1999;84:476-86.
99. Castro MR, Kocher D, Morris JC. An unusual case of inappropriate secretion of thyrotropin, neoplastic or non neoplastic. Endocr Pract 2000;6:29-33.
100. Larsen PR, Davies TF, Hay I. The thyroid gland. In: Wilson JD, et al, editors. Williams textbook of endocrinology. 9th edition. Philadelphia: WB Saunders; 1998. p. 389-515.
101. Harris AS. Clinical experience with desmopressin: efficacy and safety in chronic diabetes insipidus and other conditions. J Pediatr 1989;114:711-8.
102. Stenberg A, Lackgren G. Desmopressin tablets in the treatment of severe nocturnal enuresis in adolescents. Pediatrics 1994;94:841-6.
103. Durr JA. DI in pregnancy. Am J Kidney Dis 1987;9:276-83.
104. Rubens R, Thiery M. DI in pregnancy. Eur J Obstet Gynecol Reprod Bio 1987;26:265-70.
105. Webster B, Bain J. Antidiuretic effect and complications of chlorpropamide therapy in diabetes insipidus. J Clin Endocrinol Metab 1970;30:215-27.
106. Gold PW, Robertson GL, Ballenger JC, et al. Carbamazepine diminishes the sensitivity of the plasma arginine ADH response to osmotic stimulation. J Clin Endocrinol Metab 1983;57:952-7.
107. Stokes JB. Integrated actions of renal medullary prostaglandins in the control of water excretion. Am J Physiol 1981;240:471-80.
108. Arafah BM, Prunty D, Ybarra J, et al. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in pituitary adenomas. J Clin Endocrinol Metab 2000;85:1789-93.
109. Mason RB, Nierman LK, Doppman JL, et al. Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function. J Neurosurg 1997;87:343-51.
110. Kelly DF, Gonzalo IT, Cohan P, et al. Hypopituitarism following traumatic brain injury and aneurysmal subarachnoid hemorrhage; a preliminary report. J Neurosurg 2000;93:743-52.
111. Streeten DHP, Anderson Jr GH, Bonaventura MM. The potential for serious consequences from misinterpreting normal responses to the rapid adrenocorticotropin test. J Clin Endocrinol Metab 1996;81:285-90.
112. Dickstein G, Spigel D, Arad E, et al. One microgram is the lowest ACTH dose to cause a maximal cortisol response: there is no diurnal variation of cortisol response to submaximal ACTH stimulation. Eur J Endocrinol 1997;13:7172-5.
113. Eddy RL, Gilliland PF, Ibarra Jr JE. Human growth hormone release. Comparison of provocative test procedures. Am J Med 1974;56:179-85.
114. Ghigo E, Aimaretti G, Arvat E, et al. Growth hormone releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults. Endocr J 2001;15:29-38.
115. Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency. Summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. J Clin Endocrinol Metab 1998;83:379-81.
116. Murray RD, Skillicorn CJ, Howell SJ, et al. Influences on quality of life in growth hormone deficient adults and their effect on response to treatment. Clin Endocrinol 1999;51:565-73.
117. Shalet SM. GH therapy for adult growth hormone deficiency. Int J Clin Pract 1998;52:108-11.
118. Miller M, Dalakos T, Moses AM, et al. Recognition of partial defects in antidiuretic hormone secretion. Ann Intern Med 1970;73:721-9.
119. Krammer H, George R. Cushing's disease in a patient with an ectopic pituitary adenoma. JAMA 1981;246:2722-4.
120. Pluta RM, Niemann L, Doppman JL, et al. Extrapituitary microadenoma in Cushing's disease. J Clin Endocrinol Metab 1999;84:2912-23.